C4 Therapeutics, Inc. financial data

Symbol
CCCC on Nasdaq
Location
Watertown, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 598% % 8.8%
Debt-to-equity 59% % 5.1%
Return On Equity -54% % -23%
Return On Assets -34% % -21%
Operating Margin -321% % 4.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 97,578,175 shares 37%
Common Stock, Shares, Outstanding 96,914,418 shares 37%
Entity Public Float $100,051,846 USD -67%
Common Stock, Value, Issued $9,000 USD 29%
Weighted Average Number of Shares Outstanding, Basic 82,894,459 shares 19%
Weighted Average Number of Shares Outstanding, Diluted 82,894,459 shares 19%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $35,947,000 USD 1%
Research and Development Expense $104,240,000 USD -5.8%
General and Administrative Expense $36,196,000 USD -14%
Operating Income (Loss) $115,222,000 USD 3.7%
Nonoperating Income (Expense) $10,349,000 USD -28%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $104,873,000 USD 0.3%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $104,994,000 USD 0.31%
Earnings Per Share, Basic -1.27 USD/shares 16%
Earnings Per Share, Diluted -1.27 USD/shares 16%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $74,603,000 USD 34%
Cash, Cash Equivalents, and Short-term Investments $297,100,000 USD 11%
Accounts Receivable, after Allowance for Credit Loss, Current $2,401,000 USD -23%
Assets, Current $258,110,000 USD 0.13%
Property, Plant and Equipment, Net $4,744,000 USD -19%
Operating Lease, Right-of-Use Asset $40,532,000 USD -30%
Other Assets, Noncurrent $3,683,000 USD 39%
Assets $359,075,000 USD 2.7%
Accounts Payable, Current $858,000 USD -35%
Contract with Customer, Liability, Current $12,493,000 USD -33%
Liabilities, Current $33,032,000 USD -27%
Contract with Customer, Liability, Noncurrent $15,841,000 USD -44%
Operating Lease, Liability, Noncurrent $53,615,000 USD -11%
Liabilities $102,488,000 USD -23%
Accumulated Other Comprehensive Income (Loss), Net of Tax $50,000 USD -5.7%
Retained Earnings (Accumulated Deficit) $738,693,000 USD -17%
Stockholders' Equity Attributable to Parent $256,587,000 USD 19%
Liabilities and Equity $359,075,000 USD 2.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $33,285,000 USD -84%
Net Cash Provided by (Used in) Financing Activities $46,000 USD -100%
Net Cash Provided by (Used in) Investing Activities $29,125,000 USD
Common Stock, Shares Authorized 300,000,000 shares 100%
Common Stock, Shares, Issued 96,914,418 shares 37%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $4,206,000 USD 89%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $78,046,000 USD 32%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $203,637,000 USD 17%
Deferred Tax Assets, Gross $216,503,000 USD 13%
Operating Lease, Liability $59,982,000 USD -8.8%
Depreciation $1,541,000 USD 4.6%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $104,997,000 USD 0.13%
Lessee, Operating Lease, Liability, to be Paid $71,125,000 USD -11%
Property, Plant and Equipment, Gross $15,521,000 USD 2.9%
Operating Lease, Liability, Current $6,367,000 USD 10%
Lessee, Operating Lease, Liability, to be Paid, Year Two $9,646,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $9,366,000 USD 3%
Operating Lease, Weighted Average Discount Rate, Percent 0.053 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $11,143,000 USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Three $11,362,000 USD 18%
Deferred Tax Assets, Operating Loss Carryforwards $100,151,000 USD 60%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $12,413,000 USD 9.2%
Operating Lease, Payments $2,249,000 USD 3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $456,000 USD 1.8%
Share-based Payment Arrangement, Expense $19,099,000 USD -36%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%